These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 28877434

  • 1. Reduction-Responsive Polypeptide Micelles for Intracellular Delivery of Antineoplastic Agent.
    Xu W, Ding J, Chen X.
    Biomacromolecules; 2017 Oct 09; 18(10):3291-3301. PubMed ID: 28877434
    [Abstract] [Full Text] [Related]

  • 2. Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma.
    Yin F, Wang Z, Jiang Y, Zhang T, Wang Z, Hua Y, Song Z, Liu J, Xu W, Xu J, Cai Z, Ding J.
    Nanomedicine; 2020 Jan 09; 23():102085. PubMed ID: 31442580
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
    Gao D, Lo PC.
    J Control Release; 2018 Jul 28; 282():46-61. PubMed ID: 29673646
    [Abstract] [Full Text] [Related]

  • 5. Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery.
    Ding J, Xu W, Zhang Y, Sun D, Xiao C, Liu D, Zhu X, Chen X.
    J Control Release; 2013 Dec 10; 172(2):444-55. PubMed ID: 23742879
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduction-responsive polypeptide nanogel delivers antitumor drug for improved efficacy and safety.
    Huang K, Shi B, Xu W, Ding J, Yang Y, Liu H, Zhuang X, Chen X.
    Acta Biomater; 2015 Nov 10; 27():179-193. PubMed ID: 26320542
    [Abstract] [Full Text] [Related]

  • 10. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
    Yang H, Shen W, Liu W, Chen L, Zhang P, Xiao C, Chen X.
    Biomacromolecules; 2018 Nov 12; 19(11):4492-4503. PubMed ID: 30346147
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.
    Cunningham AJ, Robinson M, Banquy X, Leblond J, Zhu XX.
    Mol Pharm; 2018 Mar 05; 15(3):1266-1276. PubMed ID: 29378128
    [Abstract] [Full Text] [Related]

  • 13. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X.
    Acta Biomater; 2013 Dec 05; 9(12):9330-42. PubMed ID: 23958784
    [Abstract] [Full Text] [Related]

  • 14. Comparison between novel star-like redox-sensitive amphiphilic block copolymer and its linear counterpart copolymer as nanocarriers for doxorubicin.
    Murjan S, Saeedi S, Nabid MR.
    Drug Dev Ind Pharm; 2020 Apr 05; 46(4):646-658. PubMed ID: 32208035
    [Abstract] [Full Text] [Related]

  • 15. Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.
    Sun J, Liu Y, Chen Y, Zhao W, Zhai Q, Rathod S, Huang Y, Tang S, Kwon YT, Fernandez C, Venkataramanan R, Li S.
    J Control Release; 2017 Jul 28; 258():43-55. PubMed ID: 28501705
    [Abstract] [Full Text] [Related]

  • 16. Poly(L-histidine) based copolymers: Effect of the chemically substituted L-histidine on the physio-chemical properties of the micelles and in vivo biodistribution.
    Zhang X, Chen D, Ba S, Chang J, Zhou J, Zhao H, Zhu J, Zhao X, Hu H, Qiao M.
    Colloids Surf B Biointerfaces; 2016 Apr 01; 140():176-184. PubMed ID: 26764099
    [Abstract] [Full Text] [Related]

  • 17. One-pot synthesis of crosslinked amphiphilic polycarbonates as stable but reduction-sensitive carriers for doxorubicin delivery.
    Yi X, Zhang Q, Dong H, Zhao D, Xu JQ, Zhuo R, Li F.
    Nanotechnology; 2015 Oct 02; 26(39):395602. PubMed ID: 26357961
    [Abstract] [Full Text] [Related]

  • 18. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
    Zhou Y, Wang S, Ying X, Wang Y, Geng P, Deng A, Yu Z.
    Int J Nanomedicine; 2017 Oct 02; 12():6153-6168. PubMed ID: 28883726
    [Abstract] [Full Text] [Related]

  • 19. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY, Lin Ng VW, Gao SJ, Tong YW, Hedrick JL, Yang YY.
    Biomaterials; 2014 Jan 02; 35(3):1096-108. PubMed ID: 24183698
    [Abstract] [Full Text] [Related]

  • 20. Chirality-mediated polypeptide micelles for regulated drug delivery.
    Ding J, Li C, Zhang Y, Xu W, Wang J, Chen X.
    Acta Biomater; 2015 Jan 02; 11():346-55. PubMed ID: 25278445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.